Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00176_DB06216_nanopub.RA78UJlI7ScVUIDtXZiJVNvtW6bAojauK9thl0jFkQDnY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00176_DB06216 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00176_DB06216 label "DDI between Fluvoxamine and Asenapine - Fluvoxamine is a CYP1A2 inhibitor that increases exposure of asenapine by 30%. [drugbank_resource:DB00176_DB06216]" assertion.
- drugbank_resource:DB00176_DB06216 identifier "drugbank_resource:DB00176_DB06216" assertion.
- drugbank_resource:DB00176_DB06216 title "DDI between Fluvoxamine and Asenapine - Fluvoxamine is a CYP1A2 inhibitor that increases exposure of asenapine by 30%." assertion.
- drugbank:DB00176 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00176_DB06216 assertion.
- drugbank:DB06216 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00176_DB06216 assertion.